A Live Attenuated Chimeric West Nile Virus Vaccine, rWN/DEN4{Delta}30, Is Well Tolerated and Immunogenic in Flavivirus-Naive Older Adult Volunteers

This study evaluated rWN/DEN430 in flavivirus-naive adults aged 50–65 years and found it to be safe and immunogenic. Outbreaks of WNV infection tend to be unpredictable, and a safe and effective vaccine will be an important public health tool.

Source: The Journal of Infectious Diseases - January 9, 2017 Category: Infectious Diseases Authors: Pierce, K. K., Whitehead, S. S., Kirkpatrick, B. D., Grier, P. L., Jarvis, A., Kenney, H., Carmolli, M. P., Reynolds, C., Tibery, C. M., Lovchik, J., Janiak, A., Luke, C. J., Durbin, A. P., Pletnev, A. G. Tags: VIRUSES Source Type: research